Public Profile

CSL Behring UK Limited

CSL Behring UK Limited, a subsidiary of the global biotechnology leader CSL Limited, is headquartered in Great Britain and operates extensively across Europe. Founded in 1904, CSL Behring has established itself as a pioneer in the biopharmaceutical industry, focusing on the development and manufacture of innovative therapies for rare and serious medical conditions. The company is renowned for its advanced therapies derived from human plasma, including immunoglobulins, clotting factors, and enzyme replacement therapies. These products are distinguished by their high quality and efficacy, addressing critical health needs for patients with conditions such as haemophilia and primary immunodeficiencies. With a strong market position, CSL Behring has achieved numerous accolades for its commitment to patient care and scientific excellence, solidifying its reputation as a trusted leader in the biopharmaceutical sector.

DitchCarbon Score

How does CSL Behring UK Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

CSL Behring UK Limited's score of 27 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

CSL Behring UK Limited's reported carbon emissions

CSL Behring UK Limited, headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. The absence of emissions figures suggests that the company may still be in the process of establishing its climate commitments or reporting frameworks. In the broader context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction initiatives. As such, CSL Behring UK Limited may be expected to align with industry standards and set future targets to mitigate its environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CSL Behring UK Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CSL Behring UK Limited is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CSL Behring UK Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Grifols Therapeutics, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Biotest

DE
Health and social work services (85)
Updated 1 day ago

Omrix Biopharmaceuticals Ltd.

IL
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Sanofi

FR
Pharmaceutical Preparation Manufacturing
Updated about 10 hours ago

Grifols

ES
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers